These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36570769)

  • 41. Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice.
    Kolpe A; Schepens B; Ye L; Staeheli P; Saelens X
    Antiviral Res; 2018 Oct; 158():244-254. PubMed ID: 30179634
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
    Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel Approach for Obtaining Variable Domain of New Antigen Receptor with Different Physicochemical Properties from Japanese Topeshark (
    Nakada-Masuta T; Takeda H; Uchida K
    Mar Drugs; 2023 Oct; 21(11):. PubMed ID: 37999374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of inhibition of M2 ion channel activity by BL-1743, an inhibitor of influenza A virus.
    Tu Q; Pinto LH; Luo G; Shaughnessy MA; Mullaney D; Kurtz S; Krystal M; Lamb RA
    J Virol; 1996 Jul; 70(7):4246-52. PubMed ID: 8676445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype.
    Ameiss K; Ashraf S; Kong W; Pekosz A; Wu WH; Milich D; Billaud JN; Curtiss R
    Vaccine; 2010 Sep; 28(41):6704-13. PubMed ID: 20691653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
    Li F; Ma C; Hu Y; Wang Y; Wang J
    ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development.
    Li M; Guo P; Chen C; Feng H; Zhang W; Gu C; Wen G; Rao VB; Tao P
    Front Immunol; 2021; 12():745625. PubMed ID: 34712234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function.
    Jang Y; Shin JS; Yoon YS; Go YY; Lee HW; Kwon OS; Park S; Park MS; Kim M
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30282713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice.
    Rappazzo CG; Watkins HC; Guarino CM; Chau A; Lopez JL; DeLisa MP; Leifer CA; Whittaker GR; Putnam D
    Vaccine; 2016 Mar; 34(10):1252-8. PubMed ID: 26827663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes.
    Stepanova LA; Mardanova ES; Shuklina MA; Blokhina EA; Kotlyarov RY; Potapchuk MV; Kovaleva AA; Vidyaeva IG; Korotkov AV; Eletskaya EI; Ravin NV; Tsybalova LM
    J Biomed Sci; 2018 Apr; 25(1):33. PubMed ID: 29631629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monomeric M2e antigen in VesiVax
    Adler-Moore JP; Ernst W; Kim H; Ward N; Chiang SM; Do T; Fujii G
    J Liposome Res; 2017 Sep; 27(3):210-220. PubMed ID: 28922045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a heat-stable and orally delivered recombinant M2e-expressing B. subtilis spore-based influenza vaccine.
    Zhao G; Miao Y; Guo Y; Qiu H; Sun S; Kou Z; Yu H; Li J; Chen Y; Jiang S; Du L; Zhou Y
    Hum Vaccin Immunother; 2014; 10(12):3649-58. PubMed ID: 25483702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bamboo Shark as a Small Animal Model for Single Domain Antibody Production.
    Wei L; Wang M; Xiang H; Jiang Y; Gong J; Su D; Al Azad MAR; Dong H; Feng L; Wu J; Chan LL; Yang N; Shi J
    Front Bioeng Biotechnol; 2021; 9():792111. PubMed ID: 34957081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody.
    Pejoski D; Zeng W; Rockman S; Brown LE; Jackson DC
    Immunol Cell Biol; 2010 Jul; 88(5):605-11. PubMed ID: 20177411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolation of highly selective IgNAR variable single-domains against a human therapeutic Fc scaffold and their application as tailor-made bioprocessing reagents.
    Buschhaus MJ; Becker S; Porter AJ; Barelle CJ
    Protein Eng Des Sel; 2019 Dec; 32(9):385-399. PubMed ID: 32119084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection.
    Guo Y; He L; Song N; Li P; Sun S; Zhao G; Tai W; Jiang S; Du L; Zhou Y
    Microbes Infect; 2017 Dec; 19(12):641-647. PubMed ID: 28903071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors.
    Mardanova ES; Kotlyarov RY; Kuprianov VV; Stepanova LA; Tsybalova LM; Lomonosoff GP; Ravin NV
    BMC Biotechnol; 2015 May; 15():42. PubMed ID: 26022390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. M2e-based universal influenza vaccines: a historical overview and new approaches to development.
    Mezhenskaya D; Isakova-Sivak I; Rudenko L
    J Biomed Sci; 2019 Oct; 26(1):76. PubMed ID: 31629405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. VNAR development through antigen immunization of Japanese topeshark (
    Takeda H; Ozawa T; Zenke H; Ohnuki Y; Umeda Y; Zhou W; Tomoda H; Takechi A; Narita K; Shimizu T; Miyakawa T; Ito Y; Sawasaki T
    Front Bioeng Biotechnol; 2023; 11():1265582. PubMed ID: 37771574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.